Isolation and short term cultivation of swine hepatocytes for bioartificial liver support system

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 249-253

  Li, Jun ^a   Li, Lan Juan ^a   Chao, Hong Cui ^a   Yang, Qian ^a   Liu, Xiao Li ^a   Sheng, Ji Fang ^a   Yu, Hai Ying ^a   Huang, Jian Rong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bioartificial liver support system; Cell isolation; Cell transplantation; Porcine hepatocytes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; COLLAGENASE; CREATININE; EDETIC ACID; LACTATE DEHYDROGENASE; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; BRIGHTNESS; CELL FUNCTION; CELL ISOLATION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; LIVER CELL CULTURE; NONHUMAN; PERFUSION; PHASE CONTRAST MICROSCOPY; SWINE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL TRANSPLANTATION; FEMALE; HEPATOCYTES; LIVER, ARTIFICIAL; MALE; MODELS, ANIMAL; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 20344375463     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Howard RB, Pesch LA. Preparation and partial characterization of intact isolated parenchymal cells from rat liver. Biol Chem 1968;243:3105-3114.
2. Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000;287:1258-1262.
3. Andres D, Diez-Fernandez C, Zaragoza A, Alvarez A, Cascales M. Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes. Biochem Pharmacol 2001; 61:427-435.
4. Katsura N, Ikai I, Mitaka T, Shiotani T, Yamanokuchi S, Sugimoto S, et al. Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions. J Surg Res 2002;106:115-123.
5. Parent R, Marion MJ, Furio L, Trepo C, Petit MA. Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 2004;126:1147-1156.
6. Nelson LJ, Newsome PN, Howie AF, Hadoke PW, Dabos KJ, Walker SW, et al. An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems. Eur J Gastroenterol-Hepatol 2000;12:923-930.
7. Liu XL, Li LJ, Chen Z. Isolation and primary culture of rat hepatocytes. Hepatobiliary Pancreat Dis Int 2002;1:77-79.
8. Samuel D. Clinical trials using cell xenografts. Their place in the treatment of fulminant hepatitis. Pathol Biol Paris 2000;48: 407-410.
9. Montalti R, Nardo B, Bertelli R, Beltempo P, Puviani L, Vivarelli M, et al. Donor pool expansion in liver transplantation. Liver Transpl 2003;9:254-259.
10. Rudow DL, Russo MW, Hafliger S, Emond JC, Brown RS Jr. Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors. Transplant Proc 2004;36:520-522.
11. Puviani AC, Ottolenghi C, Tassinari B, Pazzi P, Morsiani E. An update on high-yield hepatocyte isolation methods and on the potential clinical use of isolated liver cells. Comp Biochem Physiol A Mol Integr Physiol 1998;121:99-109.
12. Lazaro CA, Croager EJ, Mitchell C, Campbell JS, Yu C, Foraker J, et al. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 2003;38:1095-1106.
13. Goethals F, Krack G, Deboyser D, Vossen P, Roberfroid M. Critical biochemical functions of isolated hepatocytes as sensitive indicators of chemical toxicity. Fundam Appl Toxicol 1984;4: 441-450.
14. Bartrons R, Hue L, Van Schaftingen E, Hers HG. Hormonal control of fructose 2, 6-bisphosphate concentration in isolated rat hepatocytes. Biochem J 1983;214:829-837.
15. Dixit V, Arthur M, Reinhardt R, Gitnick G. Improved function of microencapsulated hepatocytes in a hybrid bioartificial liver support system. Artif Organs 1992;16:336-341.
16. Krasko A, Deshpande K, Bonvino S. Liver failure, transplantation, and critical care. Crit Care Clin 2003;19:155-183.
17. Min AD, Theise ND. Prospects for cell-based therapies for liver disease. Panminerva Med 2004;46:43-48.
18. Moscioni AD, Roy-Chowdhury J, Barbour R, Brown LL, Roy-Chowdhury N, Competiello LS, et al. Human liver cell transplantation. Prolonged function in athymic-Gunn and athymic-analbuminemic hybrid rats. Gastroenterology 1989;96: 1546-1551.
19. Tanaka M, Watanabe S, Masaki T, Kurokohchi K, Kinekawa F, Inoue H, et al. Fulminant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol 2004;39:804-806.
20. Wu J, Zheng SS. Liver transplantation in China: problems and their solutions. Hepatobiliary Pancreat Dis Int 2004;3:170-174.
21. Lee SW, Wang X, Chowdhury NR, Roy-Chowdhury J. Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles. Ann Hepatol 2004;3:48-53.
22. Sachs DA. The pig as a potential xenograft donor. Vet Immunol 1994;43:185-91.
23. Min AD, Theise ND. Prospects for cell-based therapies for liver disease. Panminerva Med 2004;46:43-48.
24. Di Campli C, Nestola M, Piscaglia AC, Santoliquido A, Gasbarrini G, Pola P, et al. Cell-based therapy for liver diseases. Eur Rev Med Pharmacol Sci 2003;7:41-44.
25. Kobayashi N, Noguchi H, Watanabe T, Matsumura T, Totsugawa T, Fujiwara T, et al. A tightly regulated immortalized human fetal hepatocyte cell line to develop a bioartificial liver. Transplantation Proceedings 2001;33:1948-1949.
26. Liu J, Jauregui HO, Faris RA, Santangini HA, Trenkler DM, Silva PG, et al. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices. Artif Organs 2001;25:539-545.